Bayban’s Sanofi SNY Stock Holding History

Bayban’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$768	Hold	18	–	–	﹤0.01%	573
2026 Q1	$867	Sell	18 -950	-98%	-$44.3K	﹤0.01%	628
2025 Q4	$46.9K	Buy	+968	New	+$48K	0.04%	237

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bayban's SNY Position: Q2 2026 in Review

Bayban held its Sanofi (SNY) position steady in Q2 2026 at 18 shares worth $768. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Bayban first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $46.9K in Q4 2025. 679 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Bayban held 18 shares of Sanofi worth $768 as of Q2 2026.
Bayban left its Sanofi share count unchanged in Q2 2026.
Sanofi made up ﹤0.01% of Bayban's portfolio in Q2 2026, its #573 holding.
Bayban first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
Bayban's Sanofi position peaked at $46.9K in Q4 2025.
679 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.